Exelixis Inc. buy Royal Bank of Canada
Start price
13.03.25
/
50%
€33.75
Target price
13.03.26
€36.74
Performance (%)
15.17%
Price
14.01.26
€38.87
Summary
This prediction is currently active. The prediction currently has a performance of 15.17%. This prediction currently runs until 13.03.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | -1.719% | -1.719% |
| iShares Core DAX® | 0.721% | 4.566% |
| iShares Nasdaq 100 | -0.413% | 1.884% |
| iShares Nikkei 225® | 3.500% | 7.196% |
| iShares S&P 500 | 0.489% | 2.436% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its price target raised by analysts at Royal Bank of Canada from $38.00 to $40.00. They now have an "outperform" rating on the stock.
Ratings data for EXEL provided by MarketBeat